Rankings
▼
Calendar
ORGO Q1 2020 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena
ORGO
Organogenesis Holdings Inc.
$338M
Q1 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$62M
+8.1% YoY
Gross Profit
$43M
69.6% margin
Operating Income
-$15M
-24.4% margin
Net Income
-$16M
-26.4% margin
EPS (Diluted)
$-0.16
QoQ Revenue Growth
-17.3%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$22M
Stock-Based Comp.
$209,000
Balance Sheet
Total Assets
$208M
Total Liabilities
$168M
Stockholders' Equity
$40M
Cash & Equivalents
$47M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$62M
$57M
+8.1%
Gross Profit
$43M
$40M
+7.0%
Operating Income
-$15M
-$12M
-24.4%
Net Income
-$16M
-$16M
-4.1%
Revenue Segments
Advanced Wound care
$51M
83%
Surgical and Sports Medicine
$10M
17%
← FY 2020
All Quarters
Q2 2020 →